Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Enanta Pharmaceuticals, Inc. ENTA

Set alert

Price alert · ENTA

All alert types
10.52 USD +0.09 +0.81%

As of Nov 3, 3:12 PM ET

Bid
10.48 × 2
Ask
10.55 × 2
10.06 Day range 10.79
10.43 52-week range 16.85
YTD
-33.32%
1 year
-2.82%
Open
10.52
Prev close
10.43
Mkt cap
306.25M
Vol
151.72K
Avg vol
251.47K
EPS
-2.42
P/E
0.00
Div yield
0.00%
More statistics
Low
10.06
High
10.79
Forward P/E
-1.32
Beta
0.57
Short ratio
20.91
Inst. own
100.66%
Dividend
0.00
Ex-div date
Earnings
Feb 5, 2025
50-d avg
9.78
200-d avg
12.44
1y target
16.88

6M chart

Chart tools
Interval
1m5m15m30m

Signals (48)
NameDateAgo
MACD: Sell SignalOct 30, 20264 days ago
MACD: Buy SignalOct 26, 20261 week ago
MACD: Sell SignalOct 13, 20263 weeks ago
SMA: BearishOct 1, 20261 month ago
SMA: BullishSep 30, 20261 month ago
MACD: Buy SignalSep 30, 20261 month ago
SMA: BearishSep 9, 20261 month ago
MACD: Sell SignalSep 9, 20261 month ago
SMA: BearishSep 8, 20261 month ago
SMA: BullishSep 2, 20262 months ago
MACD: Buy SignalSep 2, 20262 months ago
SMA: BullishSep 1, 20262 months ago
MACD: Sell SignalSep 1, 20262 months ago
SMA: BearishAug 31, 20262 months ago
SMA: BearishAug 31, 20262 months ago
SMA: BullishAug 21, 20262 months ago
SMA: BullishAug 21, 20262 months ago
SMA: BearishAug 20, 20262 months ago
SMA: BearishAug 20, 20262 months ago
SMA: BullishAug 19, 20262 months ago

Newest 20 of 48.

Analyst view

Consensus: buy

Buy
Price target (mean) 16.88 +60.5% upside
Target (low)
9.00
Target (mean)
16.88
Target (high)
27.00
Ratings (0m) 8 4 buy · 3 hold · 1 sell
  • Strong buy2
  • Buy2
  • Hold3
  • Sell0
  • Strong sell1

Recommendation trend

  • This month 8
  • 1 month ago 8
  • 2 months ago 8
  • 3 months ago 8

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

ENTA analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-1.27-1.38 – -1.16-1.58+19.8%17.67M-1.9%4
Next quarter-1.41-1.45 – -1.32-1.47+4.4%16.42M-3.7%4
Current year-5.11-5.67 – -4.70-5.48+6.7%72.47M+7.1%4
Next year-5.25-8.67 – -2.95-5.11-2.7%69.79M-3.7%3

Upgrades and downgrades

The latest rating changes

ENTA analyst upgrades and downgrades
DateFirmActionFromTo
Nov 26, 2024BairdMaintainedOutperformOutperform
Nov 26, 2024JMP SecuritiesReiteratedMarket OutperformMarket Outperform
Oct 10, 2024HC Wainwright & Co.ReiteratedBuyBuy
Oct 9, 2024JMP SecuritiesReiteratedMarket OutperformMarket Outperform
Sep 27, 2024JMP SecuritiesReiteratedMarket OutperformMarket Outperform
Aug 6, 2024JP MorganMaintainedUnderweightUnderweight
Aug 6, 2024HC Wainwright & Co.ReiteratedBuyBuy
May 7, 2024HC Wainwright & Co.MaintainedBuyBuy
May 7, 2024JMP SecuritiesMaintainedMarket OutperformMarket Outperform
Feb 8, 2024JP MorganMaintainedUnderweightUnderweight
Nov 22, 2023OppenheimerMaintainedPerformPerform
Nov 21, 2023HC Wainwright & Co.MaintainedBuyBuy
Nov 21, 2023JMP SecuritiesMaintainedOutperformOutperform
Oct 23, 2023HC Wainwright & Co.MaintainedBuyBuy
Oct 2, 2023RBC CapitalMaintainedSector PerformSector Perform
Sep 19, 2023HC Wainwright & Co.ReiteratedBuyBuy
Aug 9, 2023OppenheimerMaintainedPerformPerform
Aug 8, 2023HC Wainwright & Co.ReiteratedBuyBuy
Aug 8, 2023RBC CapitalReiteratedSector PerformSector Perform
Aug 8, 2023JMP SecuritiesMaintainedMarket OutperformMarket Outperform
Aug 8, 2023JefferiesDowngradeBuyHold
May 11, 2023OppenheimerReiteratedPerformPerform
May 9, 2023RBC CapitalMaintained—Sector Perform
May 9, 2023HC Wainwright & Co.Maintained—Buy
May 9, 2023JMP SecuritiesMaintained—Outperform
Mar 22, 2023RBC CapitalReiterated—Sector Perform
Feb 9, 2023SVB LeerinkReiterated—Market Perform
Feb 8, 2023Piper SandlerMaintained—Overweight
Feb 8, 2023JP MorganMaintained—Neutral
Jan 27, 2023SVB LeerinkMaintained—Market Perform